PURLs

Can these salt substitutes prevent complications of hypertension?

Author and Disclosure Information

 

References

Only 2 of the studies in the systematic review explicitly reported the adverse effect of hyperkalemia, and there was no statistical difference in events between randomized groups. Eight other studies reported no serious adverse events related to hyperkalemia , and 11 studies did not report on the risk for hyperkalemia.

WHAT’S NEW

High-quality data demonstrate beneficial outcomes

Previous observational and interventional studies demonstrated a BP-lowering effect of salt substitutes, but limited data with poor-quality evidence existed for the impact of salt substitutes on clinical outcomes such as mortality and CV events. This systematic review and meta-analysis suggests that ­potassium-supplemented salt may reduce BP and secondarily reduce the risk for CV events, CV mortality, and total mortality, without clear harmful effects reported.

CAVEATS

Some patient populations, comorbidities excluded from study

The study did not include patients with kidney disease or those taking potassium-sparing diuretics. Furthermore, the available data do not include primary prevention participants.

Although BP reduction due to salt substitutes may be small at an individual level, these levels of reduction may be important at a population level.

Subgroup analyses should be interpreted with caution due to the small number of trials available for individual subgroups. In addition, funnel plot asymmetry for studies reporting DBP suggests at least some effect of publication bias for that outcome.

Although BP reduction due to salt substitutes may be small at an individual level, these levels of reduction may be important at a population level.

CHALLENGES TO IMPLEMENTATION

For appropriate patients, no challenges anticipated

There are no significant challenges to implementing conclusions from this study in the primary care setting. Family physicians should be able to recommend potassium-enriched salt substitutes to patients with hypertension who are not at risk for hyperkalemia, including those with kidney disease, on potassium-­sparing diuretics, or with a history of hyperkalemia/hyperkalemic conditions. Salt substitutes, including potassium-enriched salts, are readily available in stores.

Pages

Copyright © 2023. The Family Physicians Inquiries Network. All rights reserved.

Online-Only Materials

AttachmentSize
PDF icon jfp07210342_methodology.pdf94.33 KB

Recommended Reading

These adverse events linked to improved cancer prognosis
MDedge Family Medicine
Should children know the severity of their disease? AAP weighs in with report
MDedge Family Medicine
Spironolactone safe, effective option for women with hidradenitis suppurativa
MDedge Family Medicine
What is the future for multicancer early-detection tests?
MDedge Family Medicine
Precision medicine takes individual approach to diabetes
MDedge Family Medicine
Lead pollutants as harmful to health as particulate matter
MDedge Family Medicine
Don’t fear POTS: Tips for diagnosis and treatment
MDedge Family Medicine
Inadequate sleep & obesity: Breaking the vicious cycle
MDedge Family Medicine
52-year-old man • intermittent fevers • recently received second dose of COVID-19 vaccine • tremors in all 4 extremities • Dx?
MDedge Family Medicine
Feeling salty about our sodium intake
MDedge Family Medicine